MeSH D007676 - chronic kidney failure
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Epoetin theta | Biopoin |  | 2009-10-23 |  |  |
| Mylan | Furosemide | Furosemide |  | 1986-10-29 |  |  |
| Roche | Methoxy polyethylene glycol-epoetin beta | Mircera |  | 2007-07-20 | $496.403 M | Q4/22-Q3/23 |
| Epoetin beta | NeoRecormon |  | 1997-07-16 |  |  | |
| Sandoz | Epoetin alfa | Binocrit |  | 2007-08-28 |  |  |
| Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Vitamin a, Alpha-tocopherol, Biotin, Cholecalciferol, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol | Infuvite |  | 2000-05-18 |  |  | |
| Organon | Alendronate, Cholecalciferol | Fosamax D |  | 2005-04-07 |  |  |
| AstraZeneca | Furosemide | Furosemide |  | 1985-09-09 |  |  |
| Sanofi | Furosemide | Lasix |  | 1982-01-01 |  |  |
| Wyeth | Furosemide | Furosemide |  | 1982-07-20 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
63%41/65
Phase 2
62%71/115
Phase 3
60%65/108
Approved: 14Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use